As an invested business we are in a good position to share risk in early stage application-specific research to verify relevance and potential benefits. We are committed to investing our time and resources in potential revenue-generating partnerships, offering strategic intent to advance biomanufacturing platforms with the aim of delivering value, improving efficiency and driving innovation.

We are open to opportunities for technology out-licensing, collaboration or provision of full service business models for the use of PermaLink™ or PermaCarb™. If you are looking to improve control, efficiency and post-transitional modification in the development of protein conjugates and biotherapeutics then our dedicated team would be happy to discuss the opportunities with you. Contact us directly using our info@glythera.com email address or call on +44 (0) 191 6031680